Clinical Trial

F2G and Shionogi Announce Positive Topline Results From Global Phase 3 OASIS Study Evaluating Oral Olorofim Versus AmBisome® Followed by Standard of Care in Patients With Invasive Aspergillosis

Altus Copper Applies for Partial Revocation of Failure-to-File Cease Trade Order, Announces Proposed Financing and Provides Further Corporate Update

Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - Altus Copper Corp. (the "Company") announces that it has applied to...

MIRA Pharmaceuticals Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 in Chemotherapy-Induced Peripheral Neuropathy

Randomized, double-blind, placebo-controlled study to evaluate safety, tolerability, and dose-response efficacy of oral Ketamir-2 at a leading U.S. cancer center...

QC Healthcare Launches as a Healthcare Innovation Holding Company Focused on Telehealth, Clinical Research, Pharmacy Services, Artificial Intelligence, Healthcare Analytics, and Population Health

New Organization Establishes a Strategic Platform for a Growing Portfolio of Healthcare Companies Designed to Improve Access, Outcomes, Innovation, and Healthcare...

Neurophet Showcases ‘Brain Imaging AI Solutions’ at BIO USA, Accelerates Global Business Development Collaborations

Introduces key products including an integrated brain imaging analysis solution for Alzheimer's disease treatment decision-makingExpands partnering efforts with global pharmaceutical...

error: Content is protected !!